Krka dd 2015 Annual Report with Sustainability Disclosures
The report highlights Krka Group's business performance in 2015, during which it generated €1,165 million in sales revenues and €158 million in net profit. Key achievements included the official opening of the Notol 2 solid dosage forms production plant, a €200 million investment, and the Sinteza 1 active pharmaceutical ingredients plant. The company also adopted its development strategy for 2016–2020, focusing on organic growth and expanding its presence in Western European markets. Additionally, Krka demonstrated its social responsibility through the fourth Krka's Week of Charity and Volunteering and various environmental initiatives.
Company: Krka dd
Sector: Manufacturing
Country: Slovenia
Year: 2015
Type: Annual Report with Sustainability Disclosures
Pages: 256
Back to company
Krka dd
Annual Report
The report highlights Krka Group's business performance in 2015, during which it generated €1,165 million in sales revenues and €158 million in net profit. Key achievements included the official opening of the Notol 2 solid dosage forms production plant, a €200 million investment, and the Sinteza 1 active pharmaceutical ingredients plant. The company also adopted its development strategy for 2016–2020, focusing on organic growth and expanding its presence in Western European markets. Additionally, Krka demonstrated its social responsibility through the fourth Krka's Week of Charity and Volunteering and various environmental initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Published
Mar 30, 2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
No data available
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women in Management
Employees